Loading organizations...

§ Venture Capital · Houston, TX, USA
Venture capital firm invests in early-stage healthcare services, digital health, and technology startups, providing capital & expertise.
Altitude Ventures is an early-stage venture capital firm based in Nashville, Tennessee, that invests in healthcare services, digital health, and medical technology startups. Operating with an additional office in Houston, Texas, the firm provides capital and strategic industry connections to help emerging tech-enabled healthcare companies scale. The organization manages a portfolio of over 20 active and exited healthcare companies, generating returns through management fees and carried interest on its equity investments. In January 2020, the firm expanded its assets under management by closing its second investment vehicle, Altitude Ventures Fund II, with $31.5 million in capital commitments. The firm has directed its capital toward several notable healthcare technology enterprises, including XSOLIS, BehaVR, PathAI, and Workpath. Originating out of the family office Clayton Associates, Altitude Ventures was founded in 2015 by Landon Gibbs and Jay Zeidman.
Key people at Altitude Ventures.
Key people at Altitude Ventures.
Altitude Ventures is a venture capital firm specializing in early-stage investments primarily in healthcare services and digital health companies. Founded in 2013, the firm focuses on accelerating growth for startups that innovate in healthcare by providing capital, strategic support, and operational guidance. Their investment philosophy centers on partnering with founders who aim to improve patient care and reduce healthcare costs, leveraging deep industry expertise and a value-added approach. Altitude Ventures operates mainly in the United States, with offices in Nashville, Tennessee, and Houston, Texas, and has a portfolio of about 16 investments in health tech, AI, IoT, and fintech sectors related to healthcare[1][2][5].
Altitude Ventures traces its roots to the family office of the late Clayton McWhorter, former Chairman & CEO of HCA, whose vision and leadership continue to influence the firm's culture and strategic direction. Established in 2013, the firm was founded by partners with extensive healthcare and investment experience, including managing partners such as Jay Zeidman and others. Over time, Altitude Ventures has evolved to focus more sharply on early-stage healthcare services and digital health companies, building a reputation for hands-on support and strategic partnerships that help startups scale effectively[1][2][6][7].
Altitude Ventures rides the growing trend of digital transformation in healthcare, including the rise of telehealth, AI-driven diagnostics, and cost-efficient healthcare delivery models. The timing is critical as healthcare systems globally seek innovative solutions to improve patient outcomes while controlling costs. Market forces such as increasing healthcare digitization, regulatory shifts favoring technology adoption, and rising demand for personalized care create a favorable environment for Altitude Ventures’ portfolio companies. By supporting early-stage innovators, the firm influences the broader ecosystem by accelerating the adoption of cutting-edge healthcare technologies and services[1][2][5].
Looking ahead, Altitude Ventures is poised to deepen its impact in healthcare innovation, potentially expanding its investment scope within emerging areas like AI-enabled health platforms and IoT medical devices. Trends such as value-based care, remote patient monitoring, and healthcare data interoperability will likely shape their investment focus. The firm’s continued emphasis on strategic partnerships and operational support positions it well to help startups scale and influence the healthcare sector’s evolution. As healthcare challenges grow more complex, Altitude Ventures’ role as a catalyst for transformative solutions will likely strengthen, reinforcing its legacy rooted in healthcare leadership[1][2][5].
Altitude Ventures has 14 tracked investments across 12 companies. The latest tracked deal is $3.0M Seed in Chiyo in March 2024.